Impact of Busulphan Exposure on Transplant Outcomes for Patients with Advanced Myelodysplastic Syndromes Undergoing CD34 Selected Allogeneic Hematopoietic Cell Transplantation

被引：0
|
作者：
Tamari, Roni [1 ]
Anthony, Proli [2 ]
Zheng, Juntig [3 ]
Jakubowski, Ann A. [1 ]
Papadopoulos, Esperanza B. [1 ]
Ponce, Doris M. [1 ]
Devlin, Sean [4 ]
Sauter, Craig S. [1 ]
Young, James W. [1 ]
Giralt, Sergio A. [1 ]
Castro-Malaspina, H. R. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pharm, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Stat, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Impact of TP53 Allelic State on Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasm
    Jiang, Bingqian
    Yang, Tingting
    Luo, Yi
    Zhao, Yanmin
    Ouyang, Guifang
    Yu, Jian
    Lan, Jianping
    Lu, Ying
    Lai, Xiaoyu
    Ye, Baodong
    Chen, Yi
    Liu, Lizhen
    Xu, Yang
    Shi, Pengfei
    Xiao, Haowen
    Hu, Huixian
    Guo, Qunyi
    Fu, Huarui
    Ye, Yishan
    Wang, Xinyu
    Sun, Jie
    Zheng, Weiyan
    He, Jingsong
    Zhao, Yi
    Wu, Wenjun
    Cai, Zhen
    Wei, Guoqing
    Huang, He
    Shi, Jimin
    BLOOD, 2023, 142
  • [32] Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome
    Raboud, Maude
    Beauverd, Yan
    Simonetta, Federico
    Dantin, Carole
    Pradier, Amandine
    Tsopra, Olga
    Koutsi, Aikaterini
    Mamez, Anne-Claire
    Stephan, Caroline
    Morales, Juan Felipe Rodriguez
    Polchlopek-Blasiak, Karolina
    Tirefort, Yordanka
    Masouridi-Levrat, Stavroula
    Chalandon, Yves
    BONE MARROW TRANSPLANTATION, 2018, 53 (08) : 1072 - 1075
  • [33] Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome
    Maude Raboud
    Yan Beauverd
    Federico Simonetta
    Carole Dantin
    Amandine Pradier
    Olga Tsopra
    Aikaterini Koutsi
    Anne-Claire Mamez
    Caroline Stephan
    Juan Felipe Rodriguez Morales
    Karolina Polchlopek-Blasiak
    Yordanka Tirefort
    Stavroula Masouridi-Levrat
    Yves Chalandon
    Bone Marrow Transplantation, 2018, 53 : 1072 - 1075
  • [34] Toxicities in older adult patients undergoing CD34+selected allogeneic hematopoietic stem cell transplantation (allo-HCT)
    Shah, G. L.
    Scordo, M.
    Kosuri, S.
    Herrera, D. Adrianzen
    Maloy, M.
    Nieves, J. L.
    Devlin, S.
    Avecilla, S. T.
    Meagher, R.
    Shaffer, B.
    Perales, M. -A.
    Gyurkocza, B.
    Castro-Malaspina, H.
    Giralt, S. A.
    Tamari, R.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S226 - S227
  • [35] Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation
    Itonaga, Hidehiro
    Ishiyama, Ken
    Aoki, Kazunari
    Aoki, Jun
    Ishikawa, Takayuki
    Ohashi, Kazuteru
    Fukuda, Takayuki
    Ozawa, Yukiyasu
    Ota, Shuichi
    Uchida, Naoyuki
    Eto, Tetsuya
    Iwato, Koji
    Ohno, Yuju
    Takanashi, Minoko
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Miyazaki, Yasushi
    BONE MARROW TRANSPLANTATION, 2019, 54 (09) : 1471 - 1481
  • [36] Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation
    Shah, Gunjan L.
    Scordo, Michael
    Kosuri, Satyajit
    Herrera, Diego Adrianzen
    Cho, Christina
    Devlin, Sean M.
    Borrill, Taylor
    Carlow, Dean C.
    Avecilla, Scott T.
    Meagher, Richard C.
    O'Reilly, Richard J.
    Jakubowski, Ann A.
    Papadopoulos, Esperanza B.
    Koehne, Guenther
    Gyurkocza, Boglarka
    Castro-Malaspina, Hugo
    Shaffer, Brian C.
    Perales, Miguel-Angel
    Giralt, Sergio A.
    Tamari, Roni
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (01) : 142 - 149
  • [37] Outcomes of Rituximab for EBV Viremia/Post-Transplant Lymphoproliferative Disease in CD34+Selected Allogeneic Hematopoietic Stem Cell Transplantation
    Poppiti, Kristen
    Lin, Andrew
    Adel, Nelly G.
    Hilden, Patrick
    Castro-Malaspina, Hugo
    BLOOD, 2016, 128 (22)
  • [38] The ATG dose and tlc don't impact on the development of GVHD and viral reactivations in patients undergoing cd34+selected allogeneic hematopoietic cell transplantation
    Sanchez Cayuela, A.
    Navarro, V.
    Roldan Galvan, E.
    Fox, M. L.
    Salamero Garcia, O.
    Ruiz Camps, I.
    Perez Gonzalez, A.
    Barba Sunol, P.
    Bosch Albareda, F.
    Valcarcel Ferreiras, D.
    Orti Pascual, G.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 197 - 198
  • [39] Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation
    Hidehiro Itonaga
    Ken Ishiyama
    Kazunari Aoki
    Jun Aoki
    Takayuki Ishikawa
    Kazuteru Ohashi
    Takayuki Fukuda
    Yukiyasu Ozawa
    Shuichi Ota
    Naoyuki Uchida
    Tetsuya Eto
    Koji Iwato
    Yuju Ohno
    Minoko Takanashi
    Tatsuo Ichinohe
    Yoshiko Atsuta
    Yasushi Miyazaki
    Bone Marrow Transplantation, 2019, 54 : 1471 - 1481
  • [40] Impact of Obesity on Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Myeloid Malignancies
    Voshtina, Ensi
    Szabo, Aniko
    Hamadani, Mehdi
    Fenske, Tim S.
    D'Souza, Anita
    Saber, Wael
    Drobyski, William R.
    Hari, Parameswaran
    Shah, Nirav N.
    BLOOD, 2016, 128 (22)
12345